Latest Becker's muscular dystrophy Stories
View: MDA-AVI BioPharma-YouTube for Mon. 8-15-11 (http://www.youtube.com/watch?v=4pR4a24MHvk ) View: MDA-AVI BioPharma-YouTube for Tues. 8-16-11 (http://www.youtube.com/watch?v=S3aaBZ0az4E) View: MDA-AVI BioPharma-High Res. for Mon. 8-15-11 View: MDA-AVI BioPharma-High Res. for Tues.
LONDON, July 26, 2011 /PRNewswire/ -- Great Ormond Street Hospital has announced that a team led by scientists at its research partner, UCL Institute of Child Health (ICH), funded by the Medical Research Council (MRC) and AVI BioPharma, have made an important breakthrough in the development of a treatment for Duchenne Muscular Dystrophy (DMD). Together with the MDEX Consortium, chaired by the ICH's Professor Francesco Muntoni, the group showed that a gene based drug...
Conference Includes Keynote Speaker and Acclaimed Author Seth Mnookin HACKENSACK, N.J., June 29, 2011 /PRNewswire-USNewswire/ -- Patricia A.
Grant Funds Work of Ronald G. Victor, M.D.
SOUTH PLAINFIELD, N.J., March 30, 2011 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the appointment of Robert J. Spiegel M.D., FACP as Chief Medical Officer. Dr. Spiegel served previously as Chief Medical Officer of Schering-Plough.
AMSTERDAM, March 7, 2011 /PRNewswire-FirstCall/ -- Amsterdam Molecular Therapeutics (AMT) (Euronext: AMT), a leader in the field of human gene therapy, announced today that the Duchenne Parent Project, based in the Netherlands, has awarded AMT a grant of EUR 145,000 to support the development of AMT-080, AMT's gene therapy for Duchenne Muscular Dystrophy (DMD).
Efforts over decade result in $192 million in Duchenne-specific federal investment HACKENSACK, N.J., Feb.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.